Home  |  Site Map  |  Glossary  | Contact
Text size: AA   AA   AA

Press Releases

2008 Press Releases
Listed below are all of the QLT press releases available for the year you have selected.

December 16 QLT Announces Interim Results of RADICAL Study Evaluating Visudyne® Combination Therapy PDF version
December 05 QLT Announces Commencement of Tender Offer PDF version
December 01 QLT To Repurchase Up to US$50 Million of Common Shares PDF version
October 28 QLT Announces Encouraging Phase II Data From Core Study of Punctal Plug Drug Delivery System PDF version
October 28 QLT Announces Third Quarter Results for 2008 PDF version
October 20 QLT Announces Third Quarter 2008 Visudyne® Sales PDF version
October 09 QLT Announces the Initiation of a Phase I Trial of its Synthetic Retinoid Product PDF version
September 15 QLT Announces Completion of the Redemption of 3% Convertible Senior Notes Due 2023 PDF version
September 02 QLT Completes CDN$65.5 Million Real Estate Transaction PDF version
August 26 QLT Announces Agreement to Exclusively License the Atrigel® Technology to Reckitt Benckiser Pharmaceuticals Inc. PDF version
August 11 QLT Announces Redemption of 3% Convertible Senior Notes Due 2023 PDF version
August 08 QLT Announces Removal of Conditions on CDN$65.5 Million Real Estate Transaction PDF version
July 29 QLT Announces Second Quarter Results for 2008 PDF version
July 17 QLT Announces Second Quarter 2008 Visudyne® Sales PDF version
July 14 QLT Completes Divestment of Aczone® to Allergan for USD$150 Million PDF version
June 09 QLT Announces Agreement to Sell Aczone® to Allergan for Approximately US$150 Million PDF version
June 06 QLT Announces Positive Health Canada Decision on Aczone® PDF version
May 15 QLT Inc. Announces Agreement for Sale of Real Estate PDF version
May 12 QLT Reports Initial Proof-of-Concept Data for Punctal Plug Delivery Technology PDF version
May 05 QLT Completes Enrollment in the RADICAL Study PDF version
April 25 QLT Announces First Quarter Results for 2008 PDF version
April 21 QLT Announces First Quarter 2008 Visudyne® Sales PDF version
March 31 QLT Initiates Phase II Study of Punctal Plug Drug Delivery System for Glaucoma & Ocular Hypertension PDF version
March 28 Positive Results from Visudyne® Combination Therapy Study Reported at Annual Macula Society Conference PDF version
March 17 QLT Announces Positive FDA Action on Aczone™ PDF version
February 21 QLT Announces 2007 Results PDF version
January 18 QLT Reduces Workforce as First Step in its Strategic Restructure PDF version
January 17 QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2007 PDF version
January 16 QLT Inc. Announces Initial Steps in Strategic Restructuring PDF version
Visudyne® is a registered trademark of Novartis AG
 
Copyright © 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking